Literature DB >> 1501644

Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen.

W O Rogers1, M D Rogers, R C Hedstrom, S L Hoffman.   

Abstract

Sporozoite surface protein 2 (SSP2) is a 140-kDa, protective sporozoite surface protein from Plasmodium yoelii distinct from the circumsporozoite protein (CSP). A genomic clone containing the SSP2 gene was isolated and sequenced to determine its size, structural organization and deduced primary amino acid sequence. The coding sequence consists of a single, long open reading frame encoding 826 amino acids. The overall structure of SSP2 is similar to that of the CSP, consisting of a central region of immunogenic amino acid repeats flanked by non-repetitive sequence. SSP2 has one copy of a thrombospondin repeat motif in common with several cell adhesion molecules as well as with the CSP and the thrombospondin related anonymous protein (TRAP) of P. falciparum. Additionally, SSP2 shares substantial sequence similarity to TRAP, suggesting that TRAP is the analogue of SSP2 in P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501644     DOI: 10.1016/0166-6851(92)90005-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  26 in total

1.  Two conserved amino acid motifs mediate protein targeting to the micronemes of the apicomplexan parasite Toxoplasma gondii.

Authors:  M Di Cristina; R Spaccapelo; D Soldati; F Bistoni; A Crisanti
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for plasmodium sporozoite attachment to target cells.

Authors:  C Pinzon-Ortiz; J Friedman; J Esko; P Sinnis
Journal:  J Biol Chem       Date:  2001-05-14       Impact factor: 5.157

3.  In vitro biosynthesis and in vivo processing of the major microneme antigen of Sarcocystis muris cyst merozoites.

Authors:  H Klein; H Mehlhorn; W Rüger
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

Review 4.  The development of a multivalent DNA vaccine for malaria.

Authors:  R C Hedstrom; D L Doolan; R Wang; M J Gardner; A Kumar; M Sedegah; R A Gramzinski; J B Sacci; Y Charoenvit; W R Weiss; M Margalith; J A Norman; P Hobart; S L Hoffman
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite invasion in vitro.

Authors:  P Sharma; A Bharadwaj; V K Bhasin; V N Sailaja; V S Chauhan
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Combined preparative enzymatic synthesis of dTDP-6-deoxy-4-keto-D-glucose from dTDP and sucrose.

Authors:  A Stein; M R Kula; L Elling
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

7.  CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.

Authors:  Y Charoenvit; V F Majam; G Corradin; J B Sacci; R Wang; D L Doolan; T R Jones; E Abot; M E Patarroyo; F Guzman; S L Hoffman
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 8.  A retrospective evaluation of the role of T cells in the development of malaria vaccine.

Authors:  Moriya Tsuji
Journal:  Exp Parasitol       Date:  2009-11-26       Impact factor: 2.011

9.  Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum.

Authors:  E Scarselli; R Tolle; O Koita; M Diallo; H M Müller; K Früh; O Doumbo; A Crisanti; H Bujard
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.

Authors:  O G Gómez-Duarte; M F Pasetti; A Santiago; M B Sztein; S L Hoffman; M M Levine
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.